Investigating the Immune-Activating Abilities of Aliya PEF Energy in Oncology Treatments#USA#Redwood_City#Galvanize_Therapeutics#Oncology_Treatments#Aliya_PEF_Energy
Investigating the Immune-Activating Abilities of Aliya PEF Energy in Oncology Treatments
New research highlights the immune-activating potential of Aliya PEF Energy, augmenting its use in oncology and chronic lung disease treatments.
third-news.com
August 20, 2026 at 3:06 PM
Investigating the Immune-Activating Abilities of Aliya PEF Energy in Oncology Treatments#USA#Redwood_City#Galvanize_Therapeutics#Oncology_Treatments#Aliya_PEF_Energy
EGFR Inhibitors Market: Projected Growth of 7.9% CAGR Driven by Innovative Treatments#None#targeted_therapies#EGFR_inhibitors#Oncology_Treatments
EGFR Inhibitors Market: Projected Growth of 7.9% CAGR Driven by Innovative Treatments
The EGFR inhibitors market shows promising forecasts with a 7.9% CAGR from 2026-2036, fueled by the launch of innovative therapies and rising adoption.
third-news.com
June 15, 2026 at 4:34 PM
EGFR Inhibitors Market: Projected Growth of 7.9% CAGR Driven by Innovative Treatments#None#targeted_therapies#EGFR_inhibitors#Oncology_Treatments
Radiopharmaceuticals Market Set to Hit $21.8 Billion by 2033 with 10.6% CAGR Growth#None#radiopharmaceuticals#Nuclear_Medicine#Oncology_Treatments
Radiopharmaceuticals Market Set to Hit $21.8 Billion by 2033 with 10.6% CAGR Growth
The radiopharmaceuticals market is projected to grow aggressively, reaching $21.8 billion by 2033, driven by an increase in chronic diseases and investment in R&D.
third-news.com
February 12, 2026 at 3:54 PM
Radiopharmaceuticals Market Set to Hit $21.8 Billion by 2033 with 10.6% CAGR Growth#None#radiopharmaceuticals#Nuclear_Medicine#Oncology_Treatments